ANDA 73421, held by Chase Labs Nj. Nifedipine.
As of Nov 16, 2026, ANDA 73421 (Nifedipine), held by Chase Labs Nj, was first approved by FDA on Jun 19, 1991, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 19, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nifedipine20MG ยท capsule;oral | Nifedipine | Discontinued |
| Aug 6, 1992 | Supplement 8Labeling | Approved | None posted |
| Apr 16, 1992 | Supplement 6Labeling | Approved | None posted |
| Jun 19, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters